Obbarius Alexander, Berger Heike, Stengel Andreas, Garcia Carmen, Fischer Felix, Hofmann Tobias, Rose Matthias, Uebelhack Ralf
Center for Internal Medicine and Dermatology, Department of Psychosomatic Medicine, Charité-Universitätsmedizin Berlin, Charitéplatz 1, Berlin, 10117, Germany.
Sleep Medicine Center, Charité-Universitätsmedizin Berlin, Charitéplatz 1, Berlin, 10117, Germany.
Endocrine. 2017 Apr;56(1):186-195. doi: 10.1007/s12020-017-1252-2. Epub 2017 Feb 10.
Deficiency of vitamin D is very common in obese people and treatment by oral supplementation is not effective in all patients. This exploratory pilot study investigated the influence of different doses of short-term ultraviolet B irradiation on serum 25-hydroxyvitamin-D (25D) and 1,25-dihydroxyvitamin-D (1,25D) levels in obese compared to normal weight subjects and obese controls.
Participants with skin types II and III (Fitzpatrick skin classification) were assigned to six groups including four intervention groups receiving irradiation (three groups of obese and one group of normal weight subjects) and two control groups without treatment (obese and normal weight). Intervention groups received three sessions of whole body UVB irradiation of three different doses (cumulative doses over three sessions: 0.28, 0.70, 1.75 minimal erythema dose) within 1 week of intervention. Serum 25D and 1,25D were measured at baseline and after irradiation. Outcome differences between groups were analyzed using a linear model.
Serum 25D levels increased significantly in obese (+23.6 and +26.7%, respectively, p = 0.01) and normal weight (+15.6%, p = 0.02) intervention groups who received medium and high doses of ultraviolet B irradiation compared to control groups (+3.5 and -4.0%, respectively, p = 1.0). The increase in obese patients was 51.4% greater compared to normal weight controls irradiated with equal ultraviolet B doses. Low-level ultraviolet irradiation did not result in a significant change in serum 25D (+7.0%, p = 0.61). We did not detect any significant differences of 1,25D between groups (p = 0.25).
The current study indicates that short-term ultraviolet B irradiation increases 25D levels in obese patients.
维生素D缺乏在肥胖人群中非常普遍,口服补充治疗并非对所有患者都有效。本探索性初步研究调查了与正常体重受试者和肥胖对照相比,不同剂量的短期紫外线B照射对肥胖者血清25-羟基维生素D(25D)和1,25-二羟基维生素D(1,25D)水平的影响。
皮肤类型为II型和III型(菲茨帕特里克皮肤分类)的参与者被分为六组,包括四个接受照射的干预组(三组肥胖者和一组正常体重受试者)和两个未接受治疗的对照组(肥胖者和正常体重者)。干预组在干预的1周内接受三次全身UVB照射,剂量分别为三种不同水平(三次照射的累积剂量:0.28、0.70、1.75最小红斑量)。在基线和照射后测量血清25D和1,25D。使用线性模型分析组间结果差异。
与对照组相比(分别为+3.5%和 -4.0%,p = 1.0),接受中高剂量紫外线B照射的肥胖(分别增加+23.6%和+26.7%,p = 0.01)和正常体重(增加+15.6%,p = 0.02)干预组血清25D水平显著升高。与接受相同紫外线B剂量照射的正常体重对照组相比,肥胖患者的升高幅度高51.4%。低水平紫外线照射未导致血清25D有显著变化(+7.0%,p = 0.61)。我们未检测到组间1,25D有任何显著差异(p = 0.25)。
当前研究表明,短期紫外线B照射可提高肥胖患者的25D水平。